The new HealthVerity: View from the Curisium CEO
Last week, HealthVerity announced its acquisition of Curisium, an innovator in cloud-based drug...
A better way to measure healthcare costs in closed claims data This is the second post in our four-part taXonomy X blog series (part 1 here), and here we’ll discuss one of the most common pain points in closed claims analytics: costs. Specifically,...
Last week, HealthVerity announced its acquisition of Curisium, an innovator in cloud-based drug...
July 23, 2020 - Philadelphia, PA - HealthVerity announced the biweekly update to its HealthVerity...
This week’s webinar, VBA 2.0 Building and accelerating VBA for the next era, offered a deeper look...
April 30, 2020 - Philadelphia, PA -HealthVerity announced the biweekly update to its HealthVerity...
July 9, 2020 - Philadelphia, PA - HealthVerity announced the biweekly update to its HealthVerity...
Value-based agreements unite pharma companies and payers with a mutually beneficial payment model,...
Throughout the past quarter, we’ve announced major collaborations, built on existing partnerships...
June 25, 2020 - Philadelphia, PA - HealthVerity announced the biweekly update to its HealthVerity...
June 11, 2020 - Philadelphia, PA - HealthVerity announced the biweekly update to its HealthVerity...
May 28, 2020 - Philadelphia, PA - HealthVerity announced the biweekly update to its HealthVerity...
In epidemiology, statistical power determines whether a study can accurately detect an effect of a given size with a specified probability, typically 80% or higher. When studies fall below that threshold, the consequences extend well beyond inconclus...